Related references
Note: Only part of the references are listed.Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury
Jia H. Ng et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence
Krishna Sriram et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity
Jiaofeng Huang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Kidney disease is associated with in-hospital death of patients with COVID-19
Yichun Cheng et al.
KIDNEY INTERNATIONAL (2020)
Acute kidney injury in patients hospitalized with COVID-19
Jamie S. Hirsch et al.
KIDNEY INTERNATIONAL (2020)
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
Hua Su et al.
KIDNEY INTERNATIONAL (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Management of acute kidney injury in patients with COVID-19
Claudio Ronco et al.
LANCET RESPIRATORY MEDICINE (2020)
Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy
Maurizio Cecconi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
Claudio Ronco et al.
NATURE REVIEWS NEPHROLOGY (2020)
ACE2, Much More Than Just a Receptor for SARS-COV-2
Lobelia Samavati et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Acute kidney injury in critically ill patients with COVID-19
Paul Gabarre et al.
INTENSIVE CARE MEDICINE (2020)
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19
Jan Wysocki et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
SARS-CoV-2 renal tropism associates with acute kidney injury
Fabian Braun et al.
LANCET (2020)
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Mitra K. Nadim et al.
NATURE REVIEWS NEPHROLOGY (2020)
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis
Sabato Sorrentino et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Kidney ACE2 expression: Implications for chronic kidney disease
Nicholas Maksimowski et al.
PLOS ONE (2020)
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Li Tan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
M Weber et al.
HEART (2006)
Share Paper
